DRUG · Mapped RxNorm record
Nelfinavir mesylate
Normalized identity: nelfinavir mesylateView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly
NCT00001122
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Efavirenz
Normalized identity: efavirenzView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Stavudine
Normalized identity: stavudineView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Didanosine
Normalized identity: didanosineView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIV Infectionsunresolved
Interventions
Nelfinavir mesylateDRUG · verified · RxNorm: nelfinavir mesylate
EfavirenzDRUG · verified · RxNorm: efavirenz
StavudineDRUG · verified · RxNorm: stavudine
DidanosineDRUG · verified · RxNorm: didanosine
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00001122 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.